Earnings Report·May 6, 2026
Cencora (NYSE: COR) Raises Full-Year Profit Forecast After Mixed Q2 FY2026 Results
Cencora posted Q2 FY2026 revenue of $78.4B, missing estimates, but raised its annual profit outlook on steady specialty medicine demand.
Cencora Inc. (NYSE: COR) Stock News & Analysis
Cencora Inc. (NYSE: COR) is a healthcare company, listed on the NYSE. Alpha Stocks Insight tracks COR across all major catalysts: quarterly earnings reports, analyst upgrades and downgrades, mergers and acquisitions, regulatory decisions, and significant price moves driven by sector or macro developments. This page centralises 2 articles published since May 6, 2026, providing investors with timely, data-driven analysis of Cencora Inc.'s financial performance and competitive position. New coverage is added each trading day.
COR Coverage -- 2 Articles
Earnings Report·May 6, 2026
Cencora (NASDAQ: COR) Plunges 17.38% Despite Raising Full-Year Guidance
Cencora missed Q2 estimates but raised annual guidance, yet stock fell 17.38% as investors fret over near-term margin pressure in healthcare distribution.
4 min readRead article
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.